As many readers know, I personally became a patient at the end of 2017 when I underwent a cellular orthopedic procedure to my knees. In January of 2018, I underwent a similar intervention for my hips. Included in my decision making was the desire to maintain an unlimited professional commitment, a full recreational athletic schedule, and continue to have the capacity to expand my clinical, research and educational integration. One week ago, I hosted two leading orthopedic surgeons from St. Petersburg, Russia for a full day of Cellular Orthopedic instruction. On Tuesday, I continued the initiative while performing a Bone Marrow Concentrate /Stem cell intervention into the arthritic right hip of one of my visitors. On Saturday, I participated in a full day workshop focused on subchondroplasty; an area where I have gained recognition because of my Prospective Clinical Study on the particular treatment alternative when indicated.
This past Sunday and Monday, I met with a project director of a start-up regenerative medicine company seeking to have me design and carry out a clinical trial for a next-generation Amniotic Fluid derivative. There are no published outcomes studies at this time to support the use of Amniotic Fluid offerings advertised in the newspaper. The claims regarding viable stem cells following collection, sterilization, processing, freezing and fast thawing have not withstood scientific scrutiny nor has any benefit been statistically proven. The new company behind the contemporary manufacturing process does not want to show and tell; but rather, scientifically document efficacy and that is why I am interested.
I guess the message behind this blog is that I have experienced a fabulous result in my arthritic knees and hips allowing me to enjoy a relatively symptom-free, fully active lifestyle, based on a Cellular Orthopedic option, scientifically and clinically proven to succeed. The next question is then why isn’t cellular orthopedics affective on all? While there have been several publications regarding a genetic basis for success or failure of biologic interventions, there have been few actual studies to measure Molecular Biomarkers of Knee Pathology. To that end, I am determining the fiscal reality, of recovering a patient’s synovial fluid prior to treatment and measuring those biologic markers. Lots going on, for sure; however, remember that everything I do is based on science, my previous career as an orthopedic surgeon pioneering joint replacements, and my present and ongoing efforts at evidence-based Cellular Orthopedics.
To see how I might help you postpone or avoid a total joint replacement while returning to a pain-free active lifestyle call (847) 390-7666 to schedule an appointment or view my website at WWW.SheinkopMD.com.